Bausch Health Companies Inc
Bausch Health Companies Inc (BHC) Historical Volatility
BHC's 30 day historical volatility is 87.19%, in the 86th percentile of readings over the past year. This is a high percentile, meaning Bausch Health Companies Inc shares have swung far more than usual. BHC's 30 day implied volatility sits at 65.08%, with an IV Rank of 53.57%, leaving IV 22.11 points below historical volatility. This means options are pricing in less movement than the stock has actually delivered, as of Nov 17, 2026.
Read more
Tracking BHC historical volatility helps you see how much Bausch Health Companies Inc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, BHC's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor BHC 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. BHC's 30 day historical volatility, or BHC HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing BHC's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States.
Historical Volatility
Historical movement is elevated versus the past year. The stock has been unusually active.
As of Nov 17, 2026
As of Nov 17, 2026
As of Nov 17, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →